Randomized, Double-Blind, Placebo-Controlled Acute Comparator Trials of Lisdexamfetamine and Extended-Release Methylphenidate in Adolescents With Attention-Deficit/Hyperactivity Disorder

Jeffrey H. Newcorn,Péter Nagy,Ann Childress,Glen Frick,Brian Yan,Steven R. Pliszka

Randomized, Double-Blind, Placebo-Controlled Acute Comparator Trials of Lisdexamfetamine and Extended-Release Methylphenidate in Adolescents With Attention-Deficit/Hyperactivity Disorder

2017

Jeffrey H. Newcorn
Péter Nagy
Ann Childress
Glen Frick
Brian Yan
Steven R. Pliszka

Background Psychostimulants are considered first-line pharmacotherapy for youth with attention-deficit/hyperactivity disorder (ADHD), but questions remain regarding the comparative efficacy of amphetamine- and methylphenidate-based agents.

Keywords:

Psychiatry
Placebo
Methylphenidate
Lisdexamfetamine
Attention deficit hyperactivity disorder
Pharmacotherapy
Amphetamine
Medicine
Neurology
Psychopharmacology

Correction
Source
Cite
Save
Machine Reading By IdeaReader

References

Citations